Jaguar Health logo

Jaguar Health Share Price (NASDAQ: JAGX)

$1.61

0.01

(0.63%)

Last updated on

Check the interactive Jaguar Health Stock chart to analyse performance

Jaguar Health stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.60
    Today's High:$1.63

    Day's Volatility :1.54%

  • 52 Weeks Low:$1.16
    52 Weeks High:$35.25

    52 Weeks Volatility :96.7%

Jaguar Health Stock Returns

PeriodJaguar Health IncIndex (Russel 2000)
3 Months
-59.98%
0.0%
6 Months
-88.71%
0.0%
1 Year
-94.3%
0.0%
3 Years
-99.99%
-4.7%

Jaguar Health Inc Key Stats

Check Jaguar Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.6
Open
$1.61
Today's High
$1.625
Today's Low
$1.6
Market Capitalization
$3.5M
Today's Volume
$103.7K
52 Week High
$35.25
52 Week Low
$1.1628
Revenue TTM
$11.8M
EBITDA
$-30.9M
Earnings Per Share (EPS)
$37.53
PE Ratio
0.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-319.25%

Stock Returns calculator for Jaguar Health Stock including INR - Dollar returns

The Jaguar Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Jaguar Health investment value today

Current value as on today

₹10,933

Returns

₹89,067

(-89.07%)

Returns from Jaguar Health Stock

₹94,351 (-94.35%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Jaguar Health Stock

-42%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Jaguar Health Stock from India on INDmoney has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Jaguar Health Inc

  • Name

    Holdings %

  • UBS Group AG

    0.23%

  • Tower Research Capital LLC

    0.08%

  • Royal Bank of Canada

    0.04%

Analyst Recommendation on Jaguar Health Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Jaguar Health(by analysts ranked 0 to 5 stars)

Jaguar Health Share Price Target

What analysts predicted

Upside of 1639.13%

Target:

$28.00

Current:

$1.61

Jaguar Health share price target is $28.00, a slight Upside of 1639.13% compared to current price of $1.61 as per analysts' prediction.

Jaguar Health Stock Insights

  • Price Movement

    In the last 7 days, JAGX stock has moved down by -9.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.17M → 2.97M (in $), with an average increase of 27.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -10.46M → -10.40M (in $), with an average increase of 0.6% per quarter
  • JAGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 164.2%
  • JAGX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.6%
  • Price to Sales

    ForJAGX every $1 of sales, investors are willing to pay $0.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Jaguar Health Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$11.7M
↑ 19.75%
Net Income
$-38.5M
↓ 6.8%
Net Profit Margin
-329.3%
↑ 93.81%

Jaguar Health Technicals Summary

Sell

Neutral

Buy

Jaguar Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Jaguar Health Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Jaguar Health Inc logo
-20.34%
-88.71%
-94.3%
-99.99%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.98%
-0.05%
-6.32%
Beone Medicines Ltd logo
1.77%
24.81%
59.79%
78.52%
26.86%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-21.18%
38.72%
40.03%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
69.91%
115.96%
236.5%

About Jaguar Health Inc

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.
Organization
Jaguar Health
Employees
49
CEO
Ms. Lisa A. Conte
Industry
Health Technology

Key Management of Jaguar Health Inc

NameTitle
Ms. Lisa A. Conte
Founder, CEO, President & Director
Dr. Pravin R. Chaturvedi Ph.D.
Chief Scientific Officer & Chair of Scientific Advisory Board
Mr. Jonathan S. Wolin CPA, J.D., M.B.A.
Chief of Staff, Chief Compliance Officer & General Counsel
Dr. Steven R. King Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
Ms. Carol R. Lizak M.B.A.
Chief Financial Officer
Mr. Peter Hodge
Senior Director of Investor Relations, Business Development & Special Events
Dr. Karen J. Brunke Ph.D.
Executive VP of Corporate & Business Development
Mr. David Sesin Ph.D.
Chief Manufacturing Officer
Mr. Ian H. Wendt M.B.A.
Chief Commercial Officer
Dr. Massimo Radaelli M.B.A., Ph.D.
President of Jaguar International

Important FAQs about investing in JAGX Stock from India :

What is Jaguar Health share price today?

Jaguar Health share price today is $1.61 as on at the close of the market. Jaguar Health share today touched a day high of $1.63 and a low of $1.60.

What is the 52 week high and 52 week low for Jaguar Health share?

Jaguar Health share touched a 52 week high of $35.25 and a 52 week low of $1.16. Jaguar Health stock price today i.e. is closed at $1.61, lower by 95.43% versus the 52 week high.

How to invest in Jaguar Health Stock (JAGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jaguar Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jaguar Health Shares that will get you 0.9317 shares as per Jaguar Health share price of $1.61 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jaguar Health Stock (JAGX) from India?

Indian investors can start investing in Jaguar Health (JAGX) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Jaguar Health stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Jaguar Health share’s latest price of $1.61 as on August 30, 2025 at 1:29 am IST, you will get 6.2112 shares of Jaguar Health. Learn more about fractional shares .

What are the returns that Jaguar Health has given to Indian investors in the last 5 years?

Jaguar Health stock has given -100.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?